1. Startpage
  2. Johannes Gutenberg-Universität Mainz
  3. JGU-Publikationen
Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-5767
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDotzauer, Robert-
dc.contributor.authorBöhm, Katharina-
dc.contributor.authorBrandt, Maximilian Peter-
dc.contributor.authorSparwasser, Peter-
dc.contributor.authorHaack, Maximilian-
dc.contributor.authorFrees, Sebastian Karl-
dc.contributor.authorKamal, Mohamed Mostafa-
dc.contributor.authorMager, René-
dc.contributor.authorJäger, Wolfgang-
dc.contributor.authorHöfner, Thomas-
dc.contributor.authorTsaur, Igor-
dc.contributor.authorHaferkamp, Axel-
dc.contributor.authorBorgmann, Hendrik-
dc.date.accessioned2021-10-25T09:34:25Z-
dc.date.available2021-10-25T09:34:25Z-
dc.date.issued2021-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/5776-
dc.description.abstractOBJECTIVES While the coronavirus disease 2019 (COVID-19) pandemic captures healthcare resources worldwide, data on the impact of prioritization strategies in urology during pandemic are absent. We aimed to quantitatively assess the global change in surgical and oncological clinical practice in the early COVID-19 pandemic. METHODS In this cross-sectional observational study, we designed a 12-item online survey on the global effects of the COVID-19 pandemic on clinical practice in urology. Demographic survey data, change of clinical practice, current performance of procedures, and current commencement of treatment for 5 conditions in medical urological oncology were evaluated. RESULTS 235 urologists from 44 countries responded. Out of them, 93% indicated a change of clinical practice due to COVID-19. In a 4-tiered surgery down-escalation scheme, 44% reported to make first cancellations, 23% secondary cancellations, 20% last cancellations and 13% emergency cases only. Oncological surgeries had low cancellation rates (%): transurethral resection of bladder tumor (27%), radical cystectomy (21–24%), nephroureterectomy (21%), radical nephrectomy (18%), and radical orchiectomy (8%). (Neo)adjuvant/palliative treatment is currently not started by more than half of the urologists. COVID-19 high-risk-countries had higher total cancellation rates for non-oncological procedures (78% vs. 68%, p = 0.01) and were performing oncological treatment for metastatic diseases at a lower rate (35% vs. 48%, p = 0.02). CONCLUSION The COVID-19 pandemic has affected clinical practice of 93% of urologists worldwide. The impact of implementing surgical prioritization protocols with moderate cancellation rates for oncological surgeries and delay or reduction in (neo)adjuvant/palliative treatment will have to be evaluated after the pandemic.en_GB
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleGlobal change of surgical and oncological clinical practice in urology during early COVID-19 pandemicen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-5767-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleWorld journal of urologyde
jgu.journal.volume39de
jgu.pages.start3139de
jgu.pages.end3145de
jgu.publisher.year2021-
jgu.publisher.nameSpringerde
jgu.publisher.placeBerlin u.a.de
jgu.publisher.urihttps://doi.org/10.1007/s00345-020-03333-6de
jgu.publisher.issn1433-8726de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
jgu.publisher.doi10.1007/s00345-020-03333-6
jgu.organisation.rorhttps://ror.org/023b0x485
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
dotzauer_robert-global_change_-20211025113506091.pdf912.05 kBAdobe PDFView/Open
Show simple item record